Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 12 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 3 institutions in 1 country.
Tiantang FanCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 P. R. China chemwangguannan@gmail.com 17110300011@fudan.edu.cn.ORCID https://orcid.org/0000-0002-1312-952X
Jingwen QinThe Institute for Translational Nanomedicine, Shanghai East Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine Shanghai 200092 P. R. China qliu@ametcorp.com.
Fen DongAffiliated Hospital of Jianghan University Wuhan City 430015 P. R. China.
Xiao MengNanjing Recongene Biomedical Technologies, Ltd Inc. Nanjing 210032 P. R. China.
Yanqi LiCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 P. R. China chemwangguannan@gmail.com 17110300011@fudan.edu.cn.
Ying WangCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 P. R. China chemwangguannan@gmail.com 17110300011@fudan.edu.cn.
Qing LiuThe Institute for Translational Nanomedicine, Shanghai East Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine Shanghai 200092 P. R. China qliu@ametcorp.com.
Guannan WangCollege of Medical Engineering & the Key Laboratory for Medical Functional Nanomaterials, Jining Medical University Jining 272067 P. R. China chemwangguannan@gmail.com 17110300011@fudan.edu.cn.ORCID https://orcid.org/0000-0003-3593-5589
Jining Medical University · CNShanghai East Hospital · CNWuhan Sixth Hospital · CN
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Effects on the crystallization behavior and biocompatibility of poly(LLA-ran-PDO-ran-GA) with poly(d-lactide) as nucleating agents. · full record | OpenQuestion